BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34864889)

  • 1. SARS-CoV-2 Interactome 3D: A Web interface for 3D visualization and analysis of SARS-CoV-2-human mimicry and interactions.
    Ovek D; Taweel A; Abali Z; Tezsezen E; Koroglu YE; Tsai CJ; Nussinov R; Keskin O; Gursoy A
    Bioinformatics; 2022 Feb; 38(5):1455-1457. PubMed ID: 34864889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMI-PRED: A Web Server for Structural Prediction of Host-Microbe Interactions Based on Interface Mimicry.
    Guven-Maiorov E; Hakouz A; Valjevac S; Keskin O; Tsai CJ; Gursoy A; Nussinov R
    J Mol Biol; 2020 May; 432(11):3395-3403. PubMed ID: 32061934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions.
    Yapici-Eser H; Koroglu YE; Oztop-Cakmak O; Keskin O; Gursoy A; Gursoy-Ozdemir Y
    Front Hum Neurosci; 2021; 15():656313. PubMed ID: 33833673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 envelope protein attain K
    Agrahari AK; Srivastava M; Singh M; Asthana S
    J Biomol Struct Dyn; 2023; 41(24):15305-15319. PubMed ID: 36907648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
    Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
    Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of molecular mimicry in the SARS-CoV-2-human interactome for pathogenesis of cardiovascular diseases: An update to ImitateDB.
    Tayal S; Bhatnagar S
    Comput Biol Chem; 2023 Oct; 106():107919. PubMed ID: 37463554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMI-PRED 2.0: a biologist-oriented web application for prediction of host-microbe protein-protein interaction by interface mimicry.
    Lim H; Tsai CJ; Keskin O; Nussinov R; Gursoy A
    Bioinformatics; 2022 Oct; 38(21):4962-4965. PubMed ID: 36124958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.
    Burgio S; Conway de Macario E; Macario AJ; Cappello F
    Cell Stress Chaperones; 2021 Jul; 26(4):611-616. PubMed ID: 33977496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.
    Petrenko VA; Gillespie JW; De Plano LM; Shokhen MA
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Wang P; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
    Nat Biotechnol; 2023 Jan; 41(1):128-139. PubMed ID: 36217030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
    Nadeau R; Shahryari Fard S; Scheer A; Hashimoto-Roth E; Nygard D; Abramchuk I; Chung YE; Bennett SAL; Lavallée-Adam M
    J Proteome Res; 2020 Nov; 19(11):4553-4566. PubMed ID: 33103435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nCoVDock2: a docking server to predict the binding modes between COVID-19 targets and its potential ligands.
    Liu K; Lu X; Shi H; Xu X; Kong R; Chang S
    Nucleic Acids Res; 2023 Jul; 51(W1):W365-W371. PubMed ID: 37194703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.
    Beaudoin CA; Jamasb AR; Alsulami AF; Copoiu L; van Tonder AJ; Hala S; Bannerman BP; Thomas SE; Vedithi SC; Torres PHM; Blundell TL
    Comput Struct Biotechnol J; 2021; 19():3938-3953. PubMed ID: 34234921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
    Martínez YA; Guo X; Portales-Pérez DP; Rivera G; Castañeda-Delgado JE; García-Pérez CA; Enciso-Moreno JA; Lara-Ramírez EE
    PLoS One; 2021; 16(2):e0246901. PubMed ID: 33596252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
    An H; Eun M; Yi J; Park J
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35226074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
    Gollapalli P; B S S; Rimac H; Patil P; Nalilu SK; Kandagalla S; Shetty P
    J Biomol Struct Dyn; 2022 Apr; 40(6):2701-2714. PubMed ID: 33146070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDBsum extras: SARS-CoV-2 and AlphaFold models.
    Laskowski RA; Thornton JM
    Protein Sci; 2022 Jan; 31(1):283-289. PubMed ID: 34779073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.